Cargando…
A-Kinase Anchoring Protein 9 Promotes Gastric Cancer Progression as a Downstream Effector of Cadherin 1
BACKGROUND: Genetic studies identified a dozen of frequently mutated genes in gastric cancer, such as cadherin 1 (CDH1) and A-kinase anchoring protein 9 (AKAP9). Of note, genetic alterations including depletion and amplification frameshift mutations of AKAP9 have been observed in 10–15% of gastric c...
Autores principales: | Yan, Qiang, Wu, Youliang, Li, Deguan, Li, Yongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617730/ https://www.ncbi.nlm.nih.gov/pubmed/36317124 http://dx.doi.org/10.1155/2022/2830634 |
Ejemplares similares
-
Receptor Tyrosine Kinases Amplified in Diffuse-Type Gastric Carcinoma: Potential Targeted Therapies and Novel Downstream Effectors
por: Yamaguchi, Hideki, et al.
Publicado: (2022) -
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer
por: Malpeli, Giorgio, et al.
Publicado: (2022) -
Friend or Foe: Regulation, Downstream Effectors of RRAD in Cancer
por: Sun, Zhangyue, et al.
Publicado: (2023) -
GPAA1 promotes gastric cancer progression via upregulation of GPI-anchored protein and enhancement of ERBB signalling pathway
por: Zhang, Xiao-Xin, et al.
Publicado: (2019) -
The Missing Protein: Is T-Cadherin a Previously Unknown GPI-Anchored Receptor on Platelets?
por: Balatskaya, Maria N., et al.
Publicado: (2021)